[
  {
    "ts": null,
    "headline": "Top Analyst Reports for Home Depot, Johnson & Johnson & Salesforce",
    "summary": "Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc. (HD), Johnson & Johnson (JNJ) and Salesforce, Inc. (CRM), as well as two micro-cap stocks, Preformed Line Products Company (PLPC) and Cooper-Standard Holdings Inc. (CPS).",
    "url": "https://finnhub.io/api/news?id=8407f99704ff49d24180099d8fb19f86e95097922e54be737d92d60e5ff51edd",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733434800,
      "headline": "Top Analyst Reports for Home Depot, Johnson & Johnson & Salesforce",
      "id": 131807154,
      "image": "https://media.zenfs.com/en/zacks.com/fa45364532c77b10fcebec5771585c0d",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Today's Research Daily features new research reports on 16 major stocks, including The Home Depot, Inc. (HD), Johnson & Johnson (JNJ) and Salesforce, Inc. (CRM), as well as two micro-cap stocks, Preformed Line Products Company (PLPC) and Cooper-Standard Holdings Inc. (CPS).",
      "url": "https://finnhub.io/api/news?id=8407f99704ff49d24180099d8fb19f86e95097922e54be737d92d60e5ff51edd"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson stock underperforms Thursday when compared to competitors",
    "summary": "Johnson & Johnson stock underperforms Thursday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=246568147004638defb43003e4653da83377b32f736cb3a108fa76617c66ab5e",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733416260,
      "headline": "Johnson & Johnson stock underperforms Thursday when compared to competitors",
      "id": 131874342,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Johnson & Johnson stock underperforms Thursday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=246568147004638defb43003e4653da83377b32f736cb3a108fa76617c66ab5e"
    }
  },
  {
    "ts": null,
    "headline": "Legend Biotech: The Story Brightens",
    "summary": "Legend Biotechâs Carvykti therapy is driving growth, supported by strong financials. Discover why LEGN stock has a bullish outlook from analysts.",
    "url": "https://finnhub.io/api/news?id=109d447a286610a0ce027a3c9d0928fccf60071e6807c31547ddbef814d15609",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733408082,
      "headline": "Legend Biotech: The Story Brightens",
      "id": 131798389,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1295493003/image_1295493003.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Legend Biotechâs Carvykti therapy is driving growth, supported by strong financials. Discover why LEGN stock has a bullish outlook from analysts.",
      "url": "https://finnhub.io/api/news?id=109d447a286610a0ce027a3c9d0928fccf60071e6807c31547ddbef814d15609"
    }
  },
  {
    "ts": null,
    "headline": "J&J: classification system for surgical complications",
    "summary": "Johnson & Johnson MedTech has announced a partnership with leading surgeons to develop a standardized classification system for surgical complications . The project aims to better assess and report...",
    "url": "https://finnhub.io/api/news?id=1ea0449d702c19cbe60665ebb9abe4fe71b2c6eda9e45d6dbd37717bba7b234b",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733395209,
      "headline": "J&J: classification system for surgical complications",
      "id": 131792900,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Johnson & Johnson MedTech has announced a partnership with leading surgeons to develop a standardized classification system for surgical complications . The project aims to better assess and report...",
      "url": "https://finnhub.io/api/news?id=1ea0449d702c19cbe60665ebb9abe4fe71b2c6eda9e45d6dbd37717bba7b234b"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson : MedTech Joins Experts to Define and Classify Surgical Site Outcomes",
    "summary": "Healthcare experts call for consistent definitions in the assessment, reporting, and monitoring of surgical wounds A standardized...",
    "url": "https://finnhub.io/api/news?id=25508e1587cdf66c2169cd6df9567eec9b7bdfce2ce0e7a047bbc90ce4151eed",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733389684,
      "headline": "Johnson & Johnson : MedTech Joins Experts to Define and Classify Surgical Site Outcomes",
      "id": 131791532,
      "image": "",
      "related": "JNJ",
      "source": "Finnhub",
      "summary": "Healthcare experts call for consistent definitions in the assessment, reporting, and monitoring of surgical wounds A standardized...",
      "url": "https://finnhub.io/api/news?id=25508e1587cdf66c2169cd6df9567eec9b7bdfce2ce0e7a047bbc90ce4151eed"
    }
  },
  {
    "ts": null,
    "headline": "Columbia Dividend Opportunity Fund Q3 2024 Commentary",
    "summary": "Institutional Class shares of Columbia Dividend Opportunity Fund returned 9.51% for the \nthird quarter. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=e4db43d07b7e4e8068187a3bf164970512789db26f6e7a3289ddcfb4a5000d38",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733357700,
      "headline": "Columbia Dividend Opportunity Fund Q3 2024 Commentary",
      "id": 131773941,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1283813790/image_1283813790.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Institutional Class shares of Columbia Dividend Opportunity Fund returned 9.51% for the \nthird quarter. Click here to read the full commentary. \n",
      "url": "https://finnhub.io/api/news?id=e4db43d07b7e4e8068187a3bf164970512789db26f6e7a3289ddcfb4a5000d38"
    }
  }
]